Correlation Between Anebulo Pharmaceuticals and NeoGenomics

Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and NeoGenomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and NeoGenomics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anebulo Pharmaceuticals and NeoGenomics, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and NeoGenomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of NeoGenomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and NeoGenomics.

Diversification Opportunities for Anebulo Pharmaceuticals and NeoGenomics

-0.42

Correlation Coefficient

Anebulo Pharmaceuticals  NeoGenomics

Very good diversification

The 3 months correlation between Anebulo and NeoGenomics is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and NeoGenomics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeoGenomics and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with NeoGenomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeoGenomics has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and NeoGenomics go up and down completely randomly.

Pair Corralation between Anebulo Pharmaceuticals and NeoGenomics

Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the NeoGenomics. In addition to that, Anebulo Pharmaceuticals is 3.42 times more volatile than NeoGenomics. It trades about -0.03 of its total potential returns per unit of risk. NeoGenomics is currently generating about 0.07 per unit of volatility. If you would invest  1,640  in NeoGenomics on September 13, 2024 and sell it today you would earn a total of  150.00  from holding NeoGenomics or generate 9.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Anebulo Pharmaceuticals  vs.  NeoGenomics

Anebulo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anebulo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's technical and fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NeoGenomics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in NeoGenomics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, NeoGenomics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Anebulo Pharmaceuticals and NeoGenomics

The main advantage of trading using opposite Anebulo Pharmaceuticals and NeoGenomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, NeoGenomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeoGenomics will offset losses from the drop in NeoGenomics' long position.

The idea behind Anebulo Pharmaceuticals and NeoGenomics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.